POINT Biopharma Global Inc.
POINT Biopharma Global Inc. (PNT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PNT · as of Jun 9, 2026
Key Statistics
Explore POINT Biopharma Global Inc. Data
pnt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 58.3%
The PNT analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $13.75, representing +10.00% upside from the current price of $12.50.
Competitors & Peers
pnt competitorsPNT
CBIO
CINC
CTIC
EQRX
ETHZStock Performance
Full HistoryAbout POINT Biopharma Global Inc.
POINT Biopharma Global Inc. functions as a radiopharmaceutical company dedicated to the advancement and commercialization of specialized radioligand therapies designed to combat various cancerous cond…
what is point biopharma global inc. · pnt stock overview · point biopharma global inc. company profile · who is point biopharma global inc. ceo · pnt NASDAQ · point biopharma global inc. headquarters · point biopharma global inc. business segments
About Stock Overview & Key Data
POINT Biopharma Global Inc. (PNT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 8, 2020. As of the latest trading session, PNT stock price is $12.50, with a market capitalization of $1.3B. The stock has returned +74.58% over the past 12 months and +0.00% year-to-date.
According to 12 Wall Street analysts, the consensus rating for POINT Biopharma Global Inc. stock is Buy, with an average 12-month price target of $13.75. In fiscal year 2022, POINT Biopharma Global Inc. reported revenue of $226.6M and net income of $98.3M. For detailed data — including POINT Biopharma Global Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, POINT Biopharma Global Inc. (PNT) stock price is $12.50. The stock is traded on NASDAQ under the ticker symbol PNT. The 52-week range is $6.57 – $14.35.